Corcept terminates distribution agreement with Optime Care, effective Jan 8, 2026

CORCEPT THERAPEUTICS INC

Notice of termination of Distribution Services Agreement with Optime Care given Oct 10, 2025; effective Jan 8, 2026.
Optime had been specialty pharmacy distributor for Korlym and authorized generic mifepristone.
Exclusive provider status ended Sept 15, 2025; termination is for convenience under 90-day notice provision.
Original agreement dated Aug 4, 2017, amended and restated Apr 1, 2024, with term through Mar 31, 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.